Skip to main content

Retail Clinics

  • Actavis OKed to market generic Protonix

    MORRISTOWN, N.J. — Actavis has received approval from the Food and Drug Administration to market a generic version of a popular gastroesophageal reflux disease treatment.

    The generic drug maker said it would market pantoprazole sodium delayed-release tablets in the 20-mg and 40-mg strengths. The drug is the generic equivalent of Pfizer's Protonix, which had U.S. sales of approximately $1.6 billion for the 12 months ended Dec. 31, 2010, according to IMS Health.

    Actavis said it would distribute the drug soon.

  • Take Care offers discounted sports, camp physicals

    CONSHOHOCKEN, Pa. — Take Care Health Systems announced Thursday that through April 30, the retail clinic operator will be offering sports and camp physicals for $35. The physicals, regularly $60, are administered by board-certified nurse practitioners and physician assistants at select Walgreens locations.

  • HHS secretary announced $750 million investment in prevention, public health

    WASHINGTON — Department of Health and Human Services secretary Kathleen Sebelius on Wednesday announced a $750 million investment in prevention and public health, funded through the Prevention and Public Health Fund created by the new healthcare law.

    “Prevention is something that can’t just happen in a doctor’s office,” Sebelius said. “If we are to address the big health issues of our time, from physical inactivity to poor nutrition to tobacco use, it needs to happen in local communities.”

  • American Diabetes Association teams up with Together Rx Access

    ALEXANDRIA, Va. — The American Diabetes Association is working with an organization that offers free prescription drug savings cards to help increase access to diabetes medications.

    The ADA and Together Rx Access said Wednesday that the cards can help millions of eligible uninsured patients receive savings of 25% to 40% on branded drugs, as well as savings on generics. Nearly 26 million people in the United States are living with diabetes, mostly Type 2 diabetes, many of whom lack health insurance.

  • New ScarAway scar diminishing serum enters market

    GUILFORD, Conn. — Mitchell-Vance Laboratories, which specializes in the treatment and prevention of scars, has announced the introduction of its new ScarAway scar diminishing serum.

    The product is launching at Walgreens stores nationwide in April for a suggested retail price of $17.99.

    ScarAway scar diminishing serum is designed to effectively shrink, flatten and fade hypertrophic (raised) and keloid scars, which may result from surgical procedures, injuries, burns, stretch marks or acne.

  • Upsher-Smith launches new Nexa vitamin

    MAPLE GROVE, Minn. — Upsher-Smith has amplified its Nexa prenatal vitamin line with the launch of Nexa Select Rx.

  • Stiefel announces OTC switch for acne washes

    RESEARCH TRIANGLE PARK, N.C. — GlaxoSmithKline company Stiefel has made its popular acne wash formulations available for over-the-counter use.

    Stiefel will market two products that are indicated for the treatment of acne over the counter under the PanOxyl brand: PanOxyl acne creamy wash will be available in 4% BPO and 8% BPO.

    A marketing campaign directed toward pharmacists and dermatologists will communicate details of the new PanOxyl 4% and 8% BPO acne creamy washes. The products will be available for shipment in May.

  • Intimate Bridge 2 Conception developing an OTC take-home insemination device

    PITTSBURGH — A private entrepreneur is close to introducing a take-home intracervical insemination fertilization kit to retail, according to a story published in the Pittsburgh Post-Gazette Friday. The product will be submitted for Food and Drug Administration approval in the first half of 2011. If approved, Steve Bollinger first plans to introduce the product into doctor’s offices before launching through retail pharmacy.

X
This ad will auto-close in 10 seconds